Target intelligence / Profile preview

Carbohydrate motif on pathogen

Molecular classification
Other
01

Overview

Carbohydrate motifs on pathogens refer to distinctive glycan structures present on the surfaces of bacteria, fungi, viruses, and some parasites, such as those found in lipopolysaccharides (LPS), peptidoglycan, mannan, and other glycoconjugates[1][2]. These carbohydrate structures act as pathogen-associated molecular patterns (PAMPs) that are recognized by host immune system pattern recognition receptors (PRRs), including Toll-like receptors, C-type lectins, and scavenger receptors, serving as the initial step in innate defense against infection[1][5][6]. The complexity and diversity of these motifs—resulting from numerous possible monosaccharide building blocks and various glycosidic linkages—make them highly antigenic and targets for both vaccine development (glycoconjugate vaccines) and therapeutic antibodies[2][6]. However, "carbohydrate motifs on pathogens" is not a single molecular entity or gene product but a broad descriptor for classes of molecular patterns, so it is not a conventional drug target in the sense of a receptor or enzyme; rather, these motifs as a group serve as molecular targets for recognition and immunotherapeutic intervention[2][6].

Other names
Pathogen-associated carbohydrate antigenPathogen glycan motifPathogen surface carbohydratePathogen glyco-epitope
02

Mechanism of action

Induction of immune response by antigenic stimulation Blocking pathogen-host interaction by antibody binding to carbohydrate epitopes Agglutination and opsonization through antibody targeting of carbohydrate antigens

03

Biological functions

Immune responseAntigen formationHost-pathogen interactionRecognition by pattern recognition receptors (PRRs)Modulation of immune signaling
04

Disease associations

InfectionAutoimmune diseaseInflammation
05

Safety considerations

Poor immunogenicity of carbohydrate antigens in infants and immunocompromised individualsRisk of cross-reactivity with host glycans leading to autoimmunityPotential for rapid antigenic variation in pathogens altering exposed carbohydrate motifs
06

Interacting drugs

Conjugate vaccines (e.g., meningococcal, pneumococcal, Haemophilus influenzae type b vaccines)

1 more in the full profile.

07

Biomarkers

Carbohydrate-specific antibodies (e.g., anti-LPS, anti-mannan)Circulating immune complexes containing pathogen carbohydrate motifs

Beyond the preview

Go deeper on Carbohydrate motif on pathogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbohydrate motif on pathogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call